![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2017
Bächmann, Sibylle; Ormanns, Steffen; Haas, Michael; Krüger, Stephan; Remold, Anna; Modest, Dominik Paul; Kirchner, Thomas; Jung, Andreas; Werner, Jens; Heinemann, Volker und Böck, Stefan
(2017):
Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research.
In: BMC Cancer
17:374
[PDF, 614kB]
Haas, Michael; Ormanns, Steffen; Bächmann, Sibylle; Remold, Anna; Krüger, Stephan; Westphalen, Christoph B.; Siveke, Jens T.; Wenzel, Patrick; Schlitter, Anna Melissa; Esposito, Irene; Quietzsch, Detlef; Clemens, Michael R.; Kettner, Erika; Laubender, Rüdiger P.; Jung, Andreas; Kirchner, Thomas; Böck, Stefan und Heinemann, Volker
(2017):
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer.
In: British Journal of Cancer, Bd. 116, Nr. 11: S. 1462-1469
Ormanns, Steffen; Haas, Michael; Remold, Anna; Kruger, Stephan; Holdenrieder, Stefan; Kirchner, Thomas; Heinemann, Volker und Boeck, Stefan
(2017):
The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy.
In: International Journal of Molecular Sciences, Bd. 18, Nr. 5, 1094
[PDF, 1MB]
2016
Ormanns, Steffen; Haas, Michael; Baechmann, Sibylle; Altendorf-Hofmann, Annelore; Remold, Anna; Quietzsch, Detlef; Clemens, Michael R.; Bentz, Martin; Geissler, Michael; Lambertz, Helmut; Kruger, Stephan; Kirchner, Thomas; Heinemann, Volker und Boeck, Stefan
(2016):
Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.
In: British Journal of Cancer, Bd. 115, Nr. 12: S. 1520-1529